These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial. Zink M; Kuwilsky A; Krumm B; Dressing H J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423 [TBL] [Abstract][Full Text] [Related]
14. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia. Cutler AJ; Kalali AH; Weiden PJ; Hamilton J; Wolfgang CD J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909 [TBL] [Abstract][Full Text] [Related]
15. Ziprasidone-induced hyperprolactinemia: a case report. Citil DY; Selçuk E; Karlidağ R; Unal S Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):905-6. PubMed ID: 18276052 [No Abstract] [Full Text] [Related]
16. Ziprasidone-induced tardive laryngeal dystonia: a case report. Tsai CS; Lee Y; Chang YY; Lin PY Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661 [TBL] [Abstract][Full Text] [Related]
17. Agitation and/or aggression after traumatic brain injury in the pediatric population treated with ziprasidone. Clinical article. Scott LK; Green R; McCarthy PJ; Conrad SA J Neurosurg Pediatr; 2009 Jun; 3(6):484-7. PubMed ID: 19485732 [TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory chronic daily headache with the atypical antipsychotic ziprasidone--a case series. Cahill CM; Hardiman O; Murphy KC Cephalalgia; 2005 Oct; 25(10):822-6. PubMed ID: 16162260 [No Abstract] [Full Text] [Related]
19. Ziprasidone-associated depressive state in schizophrenic patients. Kaptsan A; Dwolatzky T; Lerner V Clin Neuropharmacol; 2007; 30(6):357-61. PubMed ID: 18090461 [TBL] [Abstract][Full Text] [Related]